Soleno Therapeutics
NasdaqCM:SLNO
$ 52,63
+ $0,12 (0,23%)
52,63 $
+$0,12 (0,23%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,00
Earnings Per Share
$3,69
Revenue Per Share
98,58%
Gross Margin %
$2,72 B
Market Cap
$0,05 B
Long-Term Debt
Earnings Per Share
$0,00
Revenue Per Share
$3,69
Gross Margin %
98,58%
Market Cap
$2,72 B
Long-Term Debt
$0,05 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $0,39 $-4,38 $-2,36 $-2,87 $-5,85 $-5,85 $-13,50 $-9,60 $-26,25 $-75,00 $-126,75
Earnings Earnings $20,13M $-200,87M $-76,61M $-23,45M $-31,24M $-31,06M $-40,23M $-20,35M $-33,60M $-16,50M $-24,08M
RPS Revenue Per Share $0,00 $3,69 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $0,00 $6,59 $3,21
Revenue Revenue $0,00M $190,41M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $1,45M $0,61M
OCF Operating Cash Flow $0,00M $46,80M $-24,94M $-24,94M $0,00M $0,00M $0,00M $-17,02M $0,00M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $46,73M $0,00M $-24,94M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $-13,54M $0,00M
OM Operating Margin 0,00% 7,85% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 98,58% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $0,92 $-1,73 $-1,51 $-2,48 $-5,23 $-6,04 $-7,64 $-8,36 $-16,63 $-65,35 $-82,30
LT Debt Long-Term Debt N/A $49,86M $49,83M N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 45,86M 51,62M 45,86M 32,46M 8,17M 5,34M 5,31M 2,98M 2,12M 1,28M 0,22M 0,19M
×